The Buckle, Inc. (LON:0HQ7)

Ligand Pharmaceuticals Revenue

The Buckle had revenue of $272.12M USD in the quarter ending May 3, 2025, with 3.67% growth. This brings the company's revenue in the last twelve months to $1.23B, down -1.08% year-over-year. In the fiscal year ending February 1, 2025, The Buckle had annual revenue of $1.22B, down -3.44%.

• Revenue (ttm): $1.23B
• Revenue Growth: -1.08%
• P/S Ratio: 2.02
• Revenue / Employee: $153.42K
• Employees: 8,000
• Market Cap: 1.87B

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Feb 1, 2025	1.22B	-43.41M	-3.44%
Feb 3, 2024	1.26B	-84.09M	-6.25%
Jan 28, 2023	1.35B	50.58M	3.91%
Jan 29, 2022	1.29B	393.33M	43.64%
Jan 30, 2021	901.28M	1.02M	0.11%